• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类前列腺癌骨转移中上皮-间质转化(EMT)的分子特征。

Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis.

出版信息

Am J Transl Res. 2010 Oct 23;3(1):90-9.

PMID:21139809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2981429/
Abstract

Prostate cancer (PCa) has a predilection to metastasize to bone. Before metastasis can occur there is transition of the sessile epithelial cancer cells to become motile and invasive mesenchymal phenotypes by an important albeit transient process called Epithelial-to-Mesenchymal Transition (EMT). The cascade of molecular events triggered by this process is clinically relevant as they are associated with cancer stem-like cells (CSC), decreased senescence and eventual drug resistance phenotype. We interrogated some EMT markers that have been implicated in primary and bone metastasis of PCa using archived patient samples. Using an immunohistochemical approach, E-cadherin, Vimentin, ZEB1, Notch-1, PDGF-D and NF-κB were analyzed. Cases were microscopically scored using intensity (0, +1, +2, +3) and percentage of positive cells. Data was statistically analyzed using Fisher's Exact Test. Aberrant expression of EMT markers E-cadherin, Vimentin, PDGF-D, NF-κB, Notch-1 and ZEB1 was observed in PCa (primary tumor specimen) and bone metastasis tissues. The aberrant expression pattern varied according to the location within the tumor with higher expression was observed more at the invasive tumor front (ITF) vs. the center of the tumor. Notch-1 was significantly over-expressed in bone metastasis compared to primary PCa (p=0.057). The expression levels, intensity and % of positive cells of the remaining markers were not statistically significant in PCa vs. bone metastasis. In conclusion, protein expression analysis revealed the existence of EMT phenotype in the PCa and bone metastasis. Variation in the aberrant expression patterns at the invasive tumor front indicates the role of EMT markers in tumor invasion. Our results suggest that Notch-1 could play a role in PCa bone metastasis. Studies in larger patient cohorts are warranted before these EMT molecular markers can be translated to the clinical use.

摘要

前列腺癌 (PCa) 倾向于转移至骨骼。在转移发生之前,静止的上皮癌细胞通过一个重要但短暂的过程转变为运动和侵袭的间充质表型,这个过程称为上皮-间充质转化 (EMT)。这个过程引发的分子事件级联与癌症干细胞样细胞 (CSC)、衰老减少和最终耐药表型有关,因此具有临床相关性。我们使用存档的患者样本研究了一些 EMT 标志物,这些标志物与 PCa 的原发性和骨转移有关。我们采用免疫组织化学方法分析了 E-钙黏蛋白、波形蛋白、ZEB1、Notch-1、PDGF-D 和 NF-κB。使用显微镜对每个病例进行强度(0、+1、+2、+3)和阳性细胞百分比评分。使用 Fisher 精确检验对数据进行统计学分析。在 PCa(原发性肿瘤标本)和骨转移组织中观察到 EMT 标志物 E-钙黏蛋白、波形蛋白、PDGF-D、NF-κB、Notch-1 和 ZEB1 的异常表达。异常表达模式根据肿瘤内的位置而变化,在侵袭性肿瘤前缘 (ITF) 观察到更高的表达,而在肿瘤中心则较低。与原发性 PCa 相比,Notch-1 在骨转移中显著过表达 (p=0.057)。在 PCa 与骨转移中,其余标志物的表达水平、强度和阳性细胞百分比均无统计学差异。总之,蛋白质表达分析显示 EMT 表型存在于 PCa 和骨转移中。在侵袭性肿瘤前缘的异常表达模式的变化表明 EMT 标志物在肿瘤侵袭中的作用。我们的结果表明 Notch-1 可能在 PCa 骨转移中发挥作用。在这些 EMT 分子标志物能够转化为临床应用之前,需要在更大的患者队列中进行研究。

相似文献

1
Molecular signature of epithelial-mesenchymal transition (EMT) in human prostate cancer bone metastasis.人类前列腺癌骨转移中上皮-间质转化(EMT)的分子特征。
Am J Transl Res. 2010 Oct 23;3(1):90-9.
2
Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.E-钙黏蛋白的下调通过Notch信号通路增强前列腺癌的化疗耐药性。
Chin J Cancer. 2017 Mar 29;36(1):35. doi: 10.1186/s40880-017-0203-x.
3
Epithelial-mesenchymal transition (EMT) in vulvar cancer with and without inguinal lymph node involvement.外阴癌中腹股沟淋巴结受累与否的上皮-间充质转化(EMT)。
J Cancer Res Clin Oncol. 2022 May;148(5):1183-1193. doi: 10.1007/s00432-021-03715-2. Epub 2021 Sep 8.
4
Clinical significance of epithelial-mesenchymal transition markers in prostate cancer.上皮-间质转化标志物在前列腺癌中的临床意义
Hum Pathol. 2017 Mar;61:26-32. doi: 10.1016/j.humpath.2016.10.013. Epub 2016 Nov 4.
5
AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling.醛酮还原酶1C3(AKR1C3)是前列腺癌中一种关键的雄激素酶,通过激活细胞外调节蛋白激酶(ERK)信号通路促进上皮-间质转化和转移。
Urol Oncol. 2018 Oct;36(10):472.e11-472.e20. doi: 10.1016/j.urolonc.2018.07.005. Epub 2018 Aug 20.
6
Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.致癌性 miR-210-3p 通过 NF-κB 信号通路促进前列腺癌细胞 EMT 和骨转移。
Mol Cancer. 2017 Jul 10;16(1):117. doi: 10.1186/s12943-017-0688-6.
7
Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.上皮间质转化标志物与原发性皮肤鳞状细胞癌的转移风险增加相关,但在淋巴结转移中减弱。
J Dermatol Sci. 2013 Nov;72(2):93-102. doi: 10.1016/j.jdermsci.2013.07.001. Epub 2013 Jul 15.
8
Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.二甲双胍通过 STAT3/NF-κB 通路逆转原发性乳腺癌细胞的间充质表型。
BMC Cancer. 2019 Jul 23;19(1):728. doi: 10.1186/s12885-019-5945-1.
9
Metformin suppressed tumor necrosis factor-α-induced epithelial-mesenchymal transition in prostate cancer by inactivating the NF-κB signaling pathway.二甲双胍通过使核因子-κB信号通路失活,抑制肿瘤坏死因子-α诱导的前列腺癌上皮-间质转化。
Transl Cancer Res. 2020 Oct;9(10):6086-6095. doi: 10.21037/tcr-20-1186.
10
Morphological and immunohistochemical identification of epithelial-to-mesenchymal transition in clinical prostate cancer.临床前列腺癌中上皮-间质转化的形态学和免疫组织化学鉴定
Oncotarget. 2015 Sep 15;6(27):24488-98. doi: 10.18632/oncotarget.4177.

引用本文的文献

1
Epithelial-Mesenchymal Plasticity and Epigenetic Heterogeneity in Cancer.癌症中的上皮-间质可塑性与表观遗传异质性
Cancers (Basel). 2024 Sep 27;16(19):3289. doi: 10.3390/cancers16193289.
2
Evidence of the Link between Stroma Remodeling and Prostate Cancer Prognosis.基质重塑与前列腺癌预后之间联系的证据。
Cancers (Basel). 2024 Sep 21;16(18):3215. doi: 10.3390/cancers16183215.
3
Lowering expression of Epsin-3 inhibits migration and invasion of lung adenocarcinoma cells by inhibiting the epithelial-mesenchymal transition.下调 Epsin-3 的表达通过抑制上皮间质转化抑制肺腺癌细胞的迁移和侵袭。
Sci Rep. 2024 Jul 24;14(1):17069. doi: 10.1038/s41598-024-68193-1.
4
Tumor biomarkers for diagnosis, prognosis and targeted therapy.肿瘤标志物用于诊断、预后和靶向治疗。
Signal Transduct Target Ther. 2024 May 20;9(1):132. doi: 10.1038/s41392-024-01823-2.
5
Unveiling the potential of SLURP1 protein as a biomarker for prostate cancer screening.揭示SLURP1蛋白作为前列腺癌筛查生物标志物的潜力。
Front Oncol. 2024 Apr 15;14:1365615. doi: 10.3389/fonc.2024.1365615. eCollection 2024.
6
Epithelial-Mesenchymal Transition: A Fundamental Cellular and Microenvironmental Process in Benign and Malignant Prostate Pathologies.上皮-间质转化:良性和恶性前列腺疾病中的一种基本细胞和微环境过程
Biomedicines. 2024 Feb 11;12(2):418. doi: 10.3390/biomedicines12020418.
7
miR-410 Is a Key Regulator of Epithelial-to-Mesenchymal Transition with Biphasic Role in Prostate Cancer.miR-410是上皮-间质转化的关键调节因子,在前列腺癌中具有双相作用。
Cancers (Basel). 2023 Dec 21;16(1):48. doi: 10.3390/cancers16010048.
8
Phenotypic Characterization of 2D and 3D Prostate Cancer Cell Systems Using Electrical Impedance Spectroscopy.使用电阻抗谱技术对 2D 和 3D 前列腺癌细胞系进行表型特征分析。
Biosensors (Basel). 2023 Dec 18;13(12):1036. doi: 10.3390/bios13121036.
9
Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial-mesenchymal Transition in Aggressive Variant Prostate Cancers.单独使用拓扑替康和联合多西他赛节拍式给药抑制侵袭性前列腺癌上皮间质转化。
Cancer Res Commun. 2023 Jul 19;3(7):1286-1311. doi: 10.1158/2767-9764.CRC-22-0427. eCollection 2023 Jul.
10
Induction of Reactive Bone Stromal Fibroblasts in 3D Models of Prostate Cancer Bone Metastases.前列腺癌骨转移三维模型中反应性骨基质成纤维细胞的诱导
Biology (Basel). 2023 Jun 15;12(6):861. doi: 10.3390/biology12060861.

本文引用的文献

1
Bone metastases: molecular mechanisms and novel therapeutic interventions.骨转移:分子机制与新型治疗干预。
Med Res Rev. 2012 May;32(3):611-36. doi: 10.1002/med.20224. Epub 2010 Sep 3.
2
Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells.上皮间质转化在机制上与前列腺癌细胞中的干细胞特征相关联。
PLoS One. 2010 Aug 27;5(8):e12445. doi: 10.1371/journal.pone.0012445.
3
Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.靶向调控癌症干细胞和 EMT 的 miRNA:克服药物耐药性的新策略。
Drug Resist Updat. 2010 Aug-Oct;13(4-5):109-18. doi: 10.1016/j.drup.2010.07.001. Epub 2010 Aug 9.
4
Epithelial plasticity, cancer stem cells and bone metastasis formation.上皮细胞可塑性、癌症干细胞与骨转移形成。
Bone. 2011 Jan;48(1):37-43. doi: 10.1016/j.bone.2010.07.023. Epub 2010 Jul 27.
5
Emerging roles of PDGF-D signaling pathway in tumor development and progression.血小板衍生生长因子-D信号通路在肿瘤发生发展中的新作用。
Biochim Biophys Acta. 2010 Aug;1806(1):122-30. doi: 10.1016/j.bbcan.2010.04.003. Epub 2010 Apr 28.
6
Snail regulates cell survival and inhibits cellular senescence in human metastatic prostate cancer cell lines.蜗牛调节人转移性前列腺癌细胞系中的细胞存活并抑制细胞衰老。
Cell Biol Toxicol. 2010 Dec;26(6):553-67. doi: 10.1007/s10565-010-9163-5. Epub 2010 Apr 16.
7
Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways.Notch-1和Jagged-1的下调抑制前列腺癌细胞的生长、迁移和侵袭,并通过使Akt、mTOR和NF-κB信号通路失活诱导细胞凋亡。
J Cell Biochem. 2010 Mar 1;109(4):726-36. doi: 10.1002/jcb.22451.
8
The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness.Notch 信号通路在发育和肿瘤侵袭过程中的上皮-间充质转化(EMT)中的作用。
Curr Drug Targets. 2010 Jun;11(6):745-51. doi: 10.2174/138945010791170860.
9
Identification of selective inhibitors of cancer stem cells by high-throughput screening.通过高通量筛选鉴定癌症干细胞的选择性抑制剂。
Cell. 2009 Aug 21;138(4):645-659. doi: 10.1016/j.cell.2009.06.034. Epub 2009 Aug 13.
10
miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells.miR-200 调节 PDGF-D 介导的前列腺癌细胞上皮-间充质转化、黏附和侵袭。
Stem Cells. 2009 Aug;27(8):1712-21. doi: 10.1002/stem.101.